Biomea Fusion, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Research and development | $62.0M | $118.1M | $102.5M | $62.7M | $28.0M |
| Operating expenses | $83.5M | $144.1M | $126.1M | $83.6M | $41.7M |
| Operating income | -$83.5M | -$144.1M | -$126.1M | -$83.6M | -$41.7M |
| Income tax expense | $0 | $0 | $0 | $0 | $0 |
| Net income | -$61.8M | -$138.4M | -$117.3M | -$81.8M | -$41.6M |
| Balance Sheet | |||||
| Cash and equivalents | $55.8M | $58.3M | $176.9M | $111.9M | $145.7M |
| Current assets | $58.0M | $68.3M | $179.2M | $117.8M | $176.6M |
| Total assets | $58.6M | $79.9M | $199.9M | $129.3M | $185.7M |
| Current liabilities | $11.1M | $21.7M | $22.9M | $19.1M | $4.6M |
| Total liabilities | $29.0M | $28.4M | $30.7M | $20.8M | $6.9M |
| Stockholders' equity | $29.6M | $51.6M | $169.2M | $108.5M | $178.8M |
| Cash Flow Statement | |||||
| Cash from operations | -$70.4M | -$119.9M | -$96.6M | -$62.4M | -$35.4M |
| Depreciation and amortization | $1.4M | $1.7M | $1.5M | $691,000 | $249,000 |
| Stock-based compensation | $9.5M | $19.1M | $14.1M | $10.3M | $6.2M |
| Capital expenditure | — | $362,000 | $3.4M | $1.0M | $3.2M |
| Free cash flow | — | -$120.3M | -$100.0M | -$63.4M | -$38.6M |
| Impairments | $2.2M | $0 | $0 | — | — |
Shares outstanding 72.3M · Free float 74.5%
Annual filing data through FY ended December 31, 2025; float as of July 15, 2026.